Inogen (NASDAQ:INGN) specializes in innovative respiratory products, primarily focusing on portable oxygen concentrators for patients suffering from chronic respiratory conditions. Their aim is not just to improve patient mobility but to enhance the overall quality of life for those requiring oxygen therapy. The core of Inogen's operations is to design, manufacture, and market these portable devices, which stand out for their efficiency, reliability, and user-friendliness. Inogen is dedicated to ongoing research and development, striving to advance their technology and expand their product portfolio to meet the evolving needs of the healthcare sector. Their objective is to ensure that people worldwide can lead a more liberated life, free from the constraints that traditional oxygen therapy methods may impose.